Handelsbanken Fonder Portfolio holdings
AUM
$28.2B
1-Year Return
24.55%
This Quarter Return
+13.19%
1 Year Return
+24.55%
3 Year Return
+103.92%
5 Year Return
+192.89%
10 Year Return
–
AUM
$20.6B
AUM Growth
+$2.71B
(+15%)
Cap. Flow
+$680M
Cap. Flow
% of AUM
3.3%
Top 10 Holdings %
Top 10 Hldgs %
26.44%
Holding
1,633
New
69
Increased
616
Reduced
374
Closed
77
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$156M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Adobe
ADBE
|
+$73.7M |
| 4 |
Apple
AAPL
|
+$70.5M |
| 5 |
Core & Main
CNM
|
+$70.3M |
Top Sells
| 1 |
Linde
LIN
|
+$64.6M |
| 2 |
Reinsurance Group of America
RGA
|
+$53.5M |
| 3 |
Medtronic
MDT
|
+$38.2M |
| 4 |
Molina Healthcare
MOH
|
+$35.6M |
| 5 |
Alibaba
BABA
|
+$31.5M |
Sector Composition
| 1 | Technology | 32.7% |
| 2 | Healthcare | 19.57% |
| 3 | Financials | 10.49% |
| 4 | Industrials | 10.21% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Globus Medical
GMED
$7.89B
| $1.45M | 0.01% |
27,197
-12,500
| -31% | -$666K |
|
652
VF Corp
VFC
$5.85B
| $1.45M | 0.01% |
76,900
+24,800
| +48% | +$466K |
|
|
IMGN
653
DELISTED
Immunogen Inc
IMGN
| $1.44M | 0.01% |
48,700
+4,600
| +10% | +$136K |
|
654
AngloGold Ashanti
AU
$32.6B
| $1.44M | 0.01% |
+77,200
| New | +$1.44M |
|
655
Fidelity National Financial
FNF
$16.2B
| $1.44M | 0.01% |
28,288
-47,206
| -63% | -$2.41M |
|
656
Medpace
MEDP
$13.4B
| $1.44M | 0.01% |
4,700
| – | – |
|
657
Kinsale Capital Group
KNSL
$9.92B
| $1.44M | 0.01% |
4,300
-100
| -2% | -$33.5K |
|
658
Ternium
TX
$6.69B
| $1.44M | 0.01% |
33,781
+3,900
| +13% | +$166K |
|
659
Ascendis Pharma
ASND
$12B
| $1.43M | 0.01% |
11,367
| – | – |
|
660
New York Times
NYT
$9.37B
| $1.43M | 0.01% |
29,104
| – | – |
|
661
Synchrony
SYF
$27.8B
| $1.42M | 0.01% |
37,281
+4,694
| +14% | +$179K |
|
662
Celsius Holdings
CELH
$14.5B
| $1.42M | 0.01% |
26,100
-1,200
| -4% | -$65.4K |
|
663
Arrow Electronics
ARW
$6.54B
| $1.42M | 0.01% |
11,600
-2,100
| -15% | -$257K |
|
664
Bio-Rad Laboratories Class A
BIO
$7.49B
| $1.41M | 0.01% |
4,372
| – | – |
|
665
Starwood Property Trust
STWD
$7.6B
| $1.4M | 0.01% |
66,697
| – | – |
|
666
H&R Block
HRB
$6.73B
| $1.39M | 0.01% |
28,700
| – | – |
|
667
Chemed
CHE
$6.57B
| $1.39M | 0.01% |
2,372
| – | – |
|
668
Generac Holdings
GNRC
$10.9B
| $1.38M | 0.01% |
10,700
+1,200
| +13% | +$155K |
|
669
Donaldson
DCI
$9.34B
| $1.38M | 0.01% |
21,132
| – | – |
|
670
Liberty Global Class C
LBTYK
$3.99B
| $1.38M | 0.01% |
74,068
-217,370
| -75% | -$4.05M |
|
671
Strategy Inc Common Stock Class A
MSTR
$92.6B
| $1.38M | 0.01% |
21,860
+7,000
| +47% | +$442K |
|
672
Aramark
ARMK
$10B
| $1.38M | 0.01% |
49,000
-25,098
| -34% | -$705K |
|
673
Cummins
CMI
$55.8B
| $1.38M | 0.01% |
5,745
-15,366
| -73% | -$3.68M |
|
674
Elanco Animal Health
ELAN
$9.11B
| $1.37M | 0.01% |
92,200
+9,800
| +12% | +$146K |
|
675
Ionis Pharmaceuticals
IONS
$10.2B
| $1.37M | 0.01% |
27,011
+3,200
| +13% | +$162K |
|